Aigars Jirgensons

This inventor holds 13 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Merz Pharma Gmbh & Co Kgaa, Oxford Drug Design Limited, Merz+co. Gmbh & Co.. Active years: 2000-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aigars Jirgensons. Retrieved from https://idiyas.com/inventor/aigars-jirgensons

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 3)

% Patents Active = 69.2

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 3 (Patent Applications = 10)

Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 85(Granted Patents)

Company Filing History:

7 out of 107

Merz Pharma Gmbh & Co Kgaa

patents

3 out of 3

Oxford Drug Design Limited

Years Active: 2000-2025

Loading Chart...

Areas of Expertise:

Aminoacyl-tRNA Synthetase Inhibitors

NMDA Receptor Antagonists

Metabotropic Glutamate Receptors

Therapeutic Use

Sexual Dysfunction Treatment

Trypanocidal Agents

Tetrahydroquinolones

Limonoids

Aminocyclohexane Derivatives

Amino-Oxo-Aryl Compounds

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12247004 - 2-amino-N-(amino-oxo-aryl-lambda-sulfanylidene)acetamide compounds and their therapeutic use (2025-03-11),

2. 11802110 - 2-amino-N-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-tRNA synthetase (2023-10-31),

3. 11072581 - N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitors (2021-07-27),

4. 9403841 - Phragamalin limonoids for the treatment of sexual dysfunction (2016-08-02),

5. 8692021 - Method of preparing Neramexane or a salt thereof (2014-04-08),

6. 7598384 - Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors (2009-10-06),

7. 7550482 - Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors (2009-06-23),

8. 7238703 - [object Object] (2007-07-03),

9. 7022729 - Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists (2006-04-04),

10. 6828462 - Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists (2004-12-07),

11. 6602862 - 1-Amino-alkylcyclohexanes as trypanocidal agents (2003-08-05),

12. 6071966 - 1-amino-alkylcyclohexane NMDA receptor antagonists (2000-06-06),

13. 6034134 - 1-Amino-alkylcyclohexane NMDA receptor antagonists (2000-03-07),

Title: The Innovative Mind of Aigars Jirgensons

Introduction: Aigars Jirgensons, a talented inventor hailing from Riga, LV, is known for his groundbreaking contributions to the world of innovation.

Latest Patents: Aigars Jirgensons has recently been granted several patents for his cutting-edge inventions in the fields of technology and engineering, showcasing his continuous commitment to pushing the boundaries of what is possible.

Career Highlights: Throughout his illustrious career, Aigars Jirgensons has demonstrated a remarkable ability to transform creative ideas into tangible solutions that have the potential to revolutionize industries. His passion for innovation has led to the development of numerous groundbreaking technologies.

Collaborations: Aigars Jirgensons has collaborated with leading research institutions, universities, and companies to further enhance his inventions and bring them to the market. His collaborative spirit and dedication to excellence have earned him a reputation as a visionary in the world of inventing.

Conclusion: Aigars Jirgensons stands as a shining example of an inventor whose relentless pursuit of innovation has resulted in significant contributions to the field. His inventive spirit and dedication to pushing the boundaries of what is possible continue to inspire the next generation of innovators.

Profile summary based on public USPTO records.